MOLECULAR AND BIOLOGICAL CHARACTERISTICS OF A NOVEL HIV-2 ISOLATE, HIV-2(HOM)

被引:4
|
作者
NICK, S
DINIZ, CA
BORN, G
SAUTER, M
PEES, HW
MULLERLANTZSCH, N
JAHN, G
机构
[1] UNIV SAARLAND,VIROL ABT,HOMBURG,GERMANY
[2] UNIV SAARLAND,MED KLIN & POLIKLIN,HOMBURG,GERMANY
关键词
HIV-2(HOM); HIV-2; ENV; POL; PATHOGENICITY; ANTIBODY REACTIVITY;
D O I
10.1016/0168-1702(93)90066-V
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In 1991 a new HIV-2 isolate (HIV-2HOM) was isolated first from a German individual most likely infected in West Africa in the beginning of the 1970s. The virus was isolated from both, the plasma and the peripheral blood lymphocytes of the patient by using OKT-3-stimulated cord blood lymphocytes. The recovered viruses could be further propagated on Jurkat cells and exhibited a broad cell tropism. Biochemical and antigenic properties of HIV-2HOM were examined by radioimmunoprecipitations. For a more detailed molecular characterization, a 1520 bp DNA fragment from the env gene and a 722 bp DNA fragment from the pol gene were amplified by polymerase chain reactions, cloned and sequenced. A comparison of both sequences to prototypic HIV-2 and SIV isolates revealed a close relationship to HIV-2ST. This strain originated from an asymptomatic Senegalese individual and is supposed to be of reduced pathogenicity. Taking into account genetic data, it may be assumed that HIV-2HOM and HIV-2ST are closely related strains with different growth characteristics and pathogenic features.
引用
收藏
页码:267 / 279
页数:13
相关论文
共 50 条
  • [21] Current HIV-2 Diagnostic Strategy Overestimates HIV-2 Prevalence in China
    Qiu, Maofeng
    Liu, Xin
    Jiang, Yan
    Nkengasong, John N.
    Xing, Wenge
    Pei, Lijian
    Parekh, Bharat S.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (05) : 790 - 797
  • [22] Molecular epidemiology of HIV-2 infections in Japan
    Ibe, S.
    Yokomaku, Y.
    Hattori, J.
    Fujisaki, S.
    Iwatani, Y.
    Mamiya, N.
    Utsumi, M.
    Hamaguchi, M.
    Sugiura, W.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (08) : 337 - 337
  • [23] False negative anti-HIV-1 HIV-2 ELISAs in acute HIV-2 infection
    Christiansen, CB
    Jessen, TE
    Nielsen, C
    StaunOlsen, P
    [J]. VOX SANGUINIS, 1996, 70 (03) : 144 - 147
  • [24] 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2
    Gottlieb, Geoffrey S.
    Raugi, Dana N.
    Smith, Robert A.
    [J]. LANCET HIV, 2018, 5 (07): : E390 - E399
  • [25] MOLECULAR CHARACTERIZATION OF THE ENV GENE FROM A NON-SYNCYTIUM-INDUCING HIV-2 ISOLATE (HIV-2(ALI)) (VOL 10, PG 223, 1994)
    TAVEIRA, NC
    BEX, F
    BURNY, A
    SHARP, PM
    FERREIRA, MOS
    MONIZPEREIRA, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 431 - 431
  • [26] Novel agents for the treatment of HIV-2 infection
    Peterson, Kevin
    Rowland-Jones, Sarah
    [J]. ANTIVIRAL THERAPY, 2012, 17 (03) : 435 - 438
  • [27] EXON2 OF HIV-2 TAT CONTRIBUTES TO TRANSACTIVATION OF THE HIV-2 LTR BY INCREASING BINDING-AFFINITY TO HIV-2 TAR RNA
    RHIM, H
    RICE, AP
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (21) : 4405 - 4413
  • [28] RECOMBINANT PEPTIDES DERIVED FROM THE ENVELOPE OF HIV-2 IN THE SERODIAGNOSIS OF HIV-2 INFECTIONS
    OBERHUBER, W
    SCHULZ, TF
    HOFBAUER, JM
    HENGSTER, P
    LARCHER, C
    WACHTER, H
    DIERICH, MP
    [J]. IMMUNOBIOLOGY, 1988, 178 (1-2) : 67 - 67
  • [29] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    [J]. AIDS, 2000, 14 : S3 - S3
  • [30] HIV-2 infection and chemokine receptors usage - Clues to reduced virulence of HIV-2
    Azevedo-Pereira, JM
    Santos-Costa, Q
    Moniz-Pereira, J
    [J]. CURRENT HIV RESEARCH, 2005, 3 (01) : 3 - 16